Eli Lilly’s new weight-loss drug better than Ozempic
by Lisa Jarvis New data from an experimental drug being developed by Eli Lilly & Co. raises an intriguing question about obesity treatments: How low can the weight loss go? For a subset of patients in a mid-stage study of retatrutide, the answer seems to be very, very ...